13F-HR filed by SECTORAL ASSET MANAGEMENT INC
SECTORAL ASSET MANAGEMENT INC filed this 13F-HR for the quarter ended 2019-06-30, filed 2019-08-14, with 92 holding rows worth $836,298,000.
- Accession
- 0001104659-19-045891
- Filer
- CIK 1274413
- Filed
- 2019-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2019
A holdings report, 92 entries on the cover page, a total value of $836,298,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $836,298,000 with VALUE read as thousands by filing date, 13F file number 028-10653. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SHOCKWAVE MED INC | 82489T104 | COM | 849,811 | $48,516,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 3,324,623 | $41,491,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 1,489,957 | $37,756,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 794,868 | $36,826,000 | thousands by filing date | |
| TELADOC HEALTH INC | 87918A105 | COM | 513,166 | $34,079,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 402,641 | $29,216,000 | thousands by filing date | |
| AERIE PHARMACEUTICALS INC | 00771V108 | COM | 956,036 | $28,251,000 | thousands by filing date | |
| Gilead Sciences,Inc. | 375558103 | COM | 398,040 | $26,892,000 | thousands by filing date | |
| TANDEM DIABETES CARE INC | 875372203 | COM NEW | 319,866 | $20,638,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 450,638 | $20,279,000 | thousands by filing date | |
| RA PHARMACEUTICALS INC | 74933V108 | COM | 665,713 | $20,018,000 | thousands by filing date | |
| PORTOLA PHARMACEUTICALS INC COM | 737010108 | Stock | 721,556 | $19,576,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 117,097 | $17,793,000 | thousands by filing date | |
| NOVARTIS AG SPONSORED ADR | 66987V109 | ADR | 182,646 | $16,677,000 | thousands by filing date | |
| HILL ROM HLDGS INC | 431475102 | COM | 158,799 | $16,614,000 | thousands by filing date | |
| Pfizer Inc. | 717081103 | COM | 362,927 | $15,722,000 | thousands by filing date | |
| COLLEGIUM PHARMACEUTICAL INC | 19459J104 | COM | 1,174,847 | $15,449,000 | thousands by filing date | |
| LA JOLLA PHARMACEUTICAL CO | 503459604 | COM PAR $.0001 2 | 1,657,171 | $15,329,000 | thousands by filing date | |
| WRIGHT MED GROUP N V | N96617118 | ORD SHS | 511,173 | $15,243,000 | thousands by filing date | |
| Merck & Co.,Inc. | 58933Y105 | COM | 166,800 | $13,986,000 | thousands by filing date | |
| FIBROGEN INC | 31572Q808 | COM | 302,660 | $13,674,000 | thousands by filing date | |
| R1 RCM INC | 749397105 | COM | 1,078,872 | $13,572,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 153,101 | $13,113,000 | thousands by filing date | |
| ALLERGAN PLC | G0177J108 | SHS | 78,300 | $13,110,000 | thousands by filing date | |
| VOCERA COMMUNICATIONS INC | 92857F107 | COMMON STOCK | 381,604 | $12,181,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 226,241 | $11,900,000 | thousands by filing date | |
| Eli Lilly and Company | 532457108 | COM | 106,665 | $11,817,000 | thousands by filing date | |
| ATRICURE INC | 04963C209 | COM | 387,224 | $11,555,000 | thousands by filing date | |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 847,696 | $11,435,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 269,396 | $11,067,000 | thousands by filing date | |
| EVOLENT HEALTH INC CL A | 30050B101 | Stock | 1,358,352 | $10,799,000 | thousands by filing date | |
| STEMLINE THERAPEUTICS INC | 85858C107 | COM | 666,158 | $10,206,000 | thousands by filing date | |
| HMS HLDGS CORP | 40425J101 | COM | 311,278 | $10,082,000 | thousands by filing date | |
| Boston Scientific Corporation | 101137107 | COM | 226,576 | $9,738,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 214,697 | $9,737,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 73,199 | $9,588,000 | thousands by filing date | |
| Viewra, Inc | 92672L107 | COM | 1,071,265 | $9,438,000 | thousands by filing date | |
| ALBIREO PHARMA INC | 01345P106 | COMMON STOCK | 242,978 | $7,834,000 | thousands by filing date | |
| Medtronic Plc | G5960L103 | COM | 76,851 | $7,485,000 | thousands by filing date | |
| Cigna Corporation | 125523100 | COM | 47,313 | $7,454,000 | thousands by filing date | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 120,900 | $7,333,000 | thousands by filing date | |
| ObsEva SA | H5861P103 | COM | 643,151 | $7,274,000 | thousands by filing date | |
| Abbott Laboratories | 002824100 | COM | 83,198 | $6,997,000 | thousands by filing date | |
| FORTY SEVEN INC | 34983P104 | COM | 656,651 | $6,961,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 37,771 | $6,926,000 | thousands by filing date | |
| IRHYTHM HOLDINGS INC COM | 450056106 | Stock | 86,600 | $6,848,000 | thousands by filing date | |
| GLYCOMIMETICS INC | 38000Q102 | COM | 552,806 | $6,589,000 | thousands by filing date | |
| CHANGE HEALTHCARE INC | 15912K100 | COM | 450,550 | $6,578,000 | thousands by filing date | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 225,906 | $6,072,000 | thousands by filing date | |
| EVELO BIOSCIENCES INC | 299734103 | COM | 669,382 | $6,011,000 | thousands by filing date | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 50,598 | $5,957,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 418,900 | $5,810,000 | thousands by filing date | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 38,400 | $4,533,000 | thousands by filing date | |
| TOCAGEN INC | 888846102 | COM | 669,997 | $4,476,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 24,400 | $4,467,000 | thousands by filing date | |
| INSULET CORP COM | 45784P101 | Stock | 36,160 | $4,317,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC COM | 903214104 | COM | 1,587,437 | $4,159,000 | thousands by filing date | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 80,000 | $3,990,000 | thousands by filing date | |
| INTEC PHARMA LTD JERUSALEM | M53644106 | SHS | 879,000 | $3,815,000 | thousands by filing date | |
| MOLECULAR TEMPLATES INC | 608550109 | COM | 350,000 | $2,923,000 | thousands by filing date | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 65,063 | $2,338,000 | thousands by filing date | |
| PHASEBIO PHARMACEUTICALS INC | 717224109 | COM | 176,000 | $2,309,000 | thousands by filing date | |
| SAVARA INC | 805111101 | COM | 741,100 | $1,756,000 | thousands by filing date | |
| DR REDDYS LABS LTD ADR | 256135203 | ADR | 39,397 | $1,476,000 | thousands by filing date | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 11,227 | $1,392,000 | thousands by filing date | |
| UNIQURE NV | N90064101 | SHS | 14,500 | $1,133,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 10,984 | $1,036,000 | thousands by filing date | |
| SPRING BK PHARMACEUTICALS IN | 849431101 | COM | 276,656 | $1,021,000 | thousands by filing date | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 3,450 | $1,013,000 | thousands by filing date | |
| BECTON DICKINSON & CO | 075887109 | COM | 3,015 | $760,000 | thousands by filing date | |
| HUTCHMED CHINA LTD SPONSORED ADS | 44842L103 | ADR | 31,628 | $696,000 | thousands by filing date | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 12,589 | $439,000 | thousands by filing date | |
| ABIOMED INC | 003654100 | COM | 1,626 | $424,000 | thousands by filing date | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 17,551 | $389,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 11,800 | $232,000 | thousands by filing date | |
| MYOKARDIA INC | 62857M105 | COM | 4,051 | $203,000 | thousands by filing date | |
| ACELRX PHARMACEUTICALS INC | 00444T100 | COM | 73,778 | $187,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 17,811 | $166,000 | thousands by filing date | |
| ANTARES PHARMA INC | 036642106 | COM | 47,280 | $156,000 | thousands by filing date | |
| REVANCE THERAPEUTICS INC | 761330109 | COM | 11,234 | $146,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 11,400 | $138,000 | thousands by filing date | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 10,058 | $113,000 | thousands by filing date | |
| MEI PHARMA INC | 55279B202 | COM NEW | 44,539 | $111,000 | thousands by filing date | |
| NABRIVA THERAPEUTICS PLC | G63637105 | SHS | 38,255 | $93,000 | thousands by filing date | |
| AEGLEA BIOTHERAPEUTICS INC | 00773J103 | COM | 12,954 | $89,000 | thousands by filing date | |
| MARINUS PHARMACEUTICALS INC | 56854Q101 | COM | 16,800 | $70,000 | thousands by filing date | |
| BIOLINERX LTD-SPONS ADR | 09071M106 | SPON | 178,297 | $65,000 | thousands by filing date | |
| ABEONA THERAPEUTICS INC | 00289Y107 | COM | 12,681 | $61,000 | thousands by filing date | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 12,594 | $47,000 | thousands by filing date | |
| CLEARSIDE BIOMEDICAL INC | 185063104 | COM | 25,959 | $25,000 | thousands by filing date | |
| SIERRA ONCOLOGY INC | 82640U107 | COM | 41,076 | $23,000 | thousands by filing date | |
| TETRAPHASE PHARMACEUTICALS INC | 88165N105 | COMMON STOCK | 39,821 | $19,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-19-045891 | this filing | 2019-08-14 | acceptance time not in the bulk data set |